FDA requests first opioid removal from market after abuse sparks HIV outbreak
The US Food and Drug Administration has requested that a formulation of oxymorphone hydrochloride, marketed as Opana ER, be withdrawn from the market due to abuse, saying that the benefits of the product no longer outweigh the risks.…